Skip to content
OpenCapital
Get started

Integra LifeSciences IART Repayments Of Secured Debt

Repayments Of Secured Debt at other companies

STERIS logo
STERISSTE
——

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%—
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%—
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfSecuredDebt.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's repayments of secured debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's repayments of secured debt?
Integra LifeSciences (IART) reported repayments of secured debt of $35.59M in Q1 2026.
How has Integra LifeSciences's repayments of secured debt changed year-over-year?
Integra LifeSciences's repayments of secured debt increased by 133.5% year-over-year, from $15.24M to $35.59M.
What is the long-term trend for Integra LifeSciences's repayments of secured debt?
Over 4 years (2021 to 2025), Integra LifeSciences's repayments of secured debt has grown at a -6.7% compound annual growth rate (CAGR), from $125.5M to $94.91M.
What does repayments of secured debt mean?
This represents the cash outflows used to pay down the principal balance of secured debt obligations. It reflects the company's commitment to deleveraging or meeting contractual debt maturity schedules. Consistent repayment of secured debt is a key indicator of liquidity management and the company's ability to reduce its financial obligations over time.